Physiologically relevant iPSC-derived retinal models for ophthalmology research & drug discovery
Preview text: Physiologically relevant iPSC-derived retinal models for ophthalmology research & drug…
Image not available
No image available for this email.
- Subject
- Physiologically relevant iPSC-derived retinal models for ophthalmology research & drug discovery
- Preview text
- Physiologically relevant iPSC-derived retinal models for ophthalmology research & drug…
- From
- marketing@
axolbio.com - Brand
- Axol Bioscience
- ESP
- HubSpot
- Sent
- Thu Apr 30, 2026, 2:01 PM ET
- Sent to
- axolbio.com
- Size
- 158 KB
- Images
- 10
- Links
- 17, 8 of them buttons
- Subject length
- 97 characters
Against Axol Bioscience's usual
Sent in its busiest hour, 2 PM, which holds 50% of its emails. The subject is 97 characters; its average is 57.
Email headers
What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.
- From
- Axol Bioscience <[email protected]>
- Reply-To
- [email protected]
- Subject
- Physiologically relevant iPSC-derived retinal models for ophthalmology research & drug discovery
- Date
- Thu, 30 Apr 2026 19:01:03 +0100
- Message-ID domain
- bf06x.hubspotemail.net
- Return-Path domain
- bf06x.hubspotemail.net
- DKIM signature
- d=bf06x.hubspotemail.net s=hs2; d=axolbio.com s=hs1-6097189
- Authentication
- dkim=pass (bf06x.hubspotemail.net), dkim=pass (axolbio.com), spf=pass (bf06x.hubspotemail.net), dmarc=pass (axolbio.com)
- List-Unsubscribe
- Present, one-click
- Feedback-ID sender
- HubSpot
Servers it passed through, newest first
- from bid47xv.bf06x.hubspotemail.net [158.247.24.225] by our receiving server with ESMTPS
Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To
Sent just before and after
| Jul 11, 2026 12:54 PM | Thank you for subscribing | |
| Jul 2, 2026 2:33 PM | Physiologically relevant human iPSC-derived models and specialist services | |
| Jul 2, 2026 2:16 PM | Thank you for subscribing | |
| Jun 29, 2026 8:30 AM | Physiologically relevant human iPSC-derived models | |
| May 29, 2026 2:48 PM | iPSC-derived models and New Approach Methodologies (NAMs) | |
| Apr 30, 2026 2:01 PM | Physiologically relevant iPSC-derived retinal models for ophthalmology research & drug discovery (this email) | |
| Apr 17, 2026 8:31 AM | Thank you for subscribing |